具有人源化淋巴细胞活化基因3的非人动物
本发明提供了非人动物,以及用于制备和使用所述非人动物的方法和组合物,其中所述非人动物包含人源化的淋巴细胞活化基因3(Lag3)。在一些实施方案中,所述非人动物可以描述为具有对内源性Lag3基因座的遗传修饰,使得所述非人动物表达包含人部分和内源性部分(例如,非人部分)的Lag3多肽。 Non-human animals, and methods and compositions for making and using the same, are provided, wherein the non-human animals comprise a humanization of a Lympho...
Saved in:
| Format | Patent |
|---|---|
| Language | Chinese |
| Published |
08.10.2021
|
| Subjects | |
| Online Access | Get full text |
Cover
| Summary: | 本发明提供了非人动物,以及用于制备和使用所述非人动物的方法和组合物,其中所述非人动物包含人源化的淋巴细胞活化基因3(Lag3)。在一些实施方案中,所述非人动物可以描述为具有对内源性Lag3基因座的遗传修饰,使得所述非人动物表达包含人部分和内源性部分(例如,非人部分)的Lag3多肽。
Non-human animals, and methods and compositions for making and using the same, are provided, wherein the non-human animals comprise a humanization of a Lymphocyte activation gene 3 (Lag3). The non-human animals may be described, in some embodiments, as having a genetic modification to an endogenous Lag3 locus so that the non-human animals express a Lag3 polypeptide that includes a human portion and an endogenous portion (e.g., a non-human portion). |
|---|---|
| Bibliography: | Application Number: CN20168067496 |